tirzepatide news - Search News

Pharma giant seeks to join lawsuit against FDA over weight loss drugs

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the

Benzinga.com · 9h

Eli Lilly Joins FDA Lawsuit Over Compounded Obesity Drugs, Seeks 'Swift End' And 'To Protect Its Interests'

Eli Lilly moves to defend FDA's tirzepatide shortage resolution amid criticism over supply issues and compounding pharmacy claims.

INSIDER on MSN · 10d

The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

Reuters · 1d

Lilly asks to join lawsuit over compounded versions of its weight-loss drugs

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug Administration over the agency's decision that Lilly's blockbuster weight-loss and diabetes drugs are no longer in short supply.

Hosted on MSN · 1d

Lilly seeking to join lawsuit over compounded GLP-1 drugs

Eli Lilly (NYSE:LLY) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA's determination that weight-loss and diabetes drugs such as Lilly's (NYSE:LLY) tirzepatide are no longer in short supply.

JD Supra3h

FDA Announced Removal of Tirzepatide from the Drug Shortage List

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

FiercePharma1d

Lilly looks to 'protect its interests' by moving to join FDA lawsuit over compounded tirzepatide

After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...

thecardiologyadvisor.com1d

Tirzepatide Treatment Reduces Weight and Diabetes Risk Across 3 Years

Tirzepatide treatment was associated with reduced body weight and diabetes risk across 3 years among individuals with obesity ...

The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

FiercePharma4h

Roche projected to claim pharma's 2025 sales crown as Novo, Lilly climb rankings: Evaluate

The story of Eli Lilly and Novo Nordisk’s GLP-1 dominance is likely to play out again in 2025 as the metabolic medicine ...

Pharmaceutical Technology1d

Tirzepatide outpacing Wegovy in the obesity space

Eli Lilly and Novo Nordisk have been competing in the obesity market for the past year, making it an opportune time to review the benefits of the two most prominent obesity medications.

AOL7d

What is Compounded Tirzepatide? Here's What You Need to Know

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re starting a weight loss journey, you might have ...

Herts Advertiser 241d

NHS Mounjaro - what is it and who will be eligible?

Weight-loss injection Mounjaro, or tirzepatide, will be rolled out on the NHS gradually over a 12-year period, starting this year.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics